Title

Development of Double-Controlled Drug Eluting Stents with Nanotechnology

Authors

Brandon Park '21, Illinois Mathematics and Science AcademyFollow

Document Type

Conference Paper/Presentation

Conference

Presented at Japan Super Science Fair (JSSF) 2020

Publication Date

10-2020

Advisor(s)

Dong-Hyun Kim, PhD; Northwestern University, Feinberg School of Medicine Department of Radiology

Bo Yu, PhD, Department of Radiology Northwestern University, Feinberg School of Medicine

Bo Yu, PhD, Department of Radiology Northwestern University, Feinberg School of Medicine

Abstract

Due to the limitations or poor drug release kinetics and subsequent damage to adjacent normal digestive epithelial cells for drug eluting stents (DES), this project highlights the usage of gemcitabine-loaded mesoporous silica nanoparticles (gMSNP), which were coated onto a stent with biodegradable poly(lactic-coglycolic) acid (PLGA) polymer. The results showed improved drug release kinetics of the developed nanocomposite layers of the stent. Using our results, our DES will eventually reduce the rate of restenosis that can be induced by stents.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.

Recommended Citation

Park, B. (2020). Development of Double-Controlled Drug Eluting Stents with Nanotechnology.
Retrieved from: https://digitalcommons.imsa.edu/student_pr/71